SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-056000
Filing Date
2022-05-04
Accepted
2022-05-04 20:41:26
Documents
2
Period of Report
2022-05-03

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2214526-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2214526-1_4seq1.xml 4 5441
2 EXHIBIT 24 tm2214526d1_ex24.htm EX-24 5962
  Complete submission text file 0001104659-22-056000.txt   13012
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Issuer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CALITHERA BIOSCIENCES 343 OYSTER POINT BLVD, SUITE 200 SO. SAN FRANCISCO CA 94080
Business Address
Waddill William D. (Reporting) CIK: 0001553338 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37852 | Film No.: 22893609